Genpharm empowering the rare disease community in MENA

In Market Access by marcrhysevans

The World Orphan Drug Congress Europe 2015 will be going into it’s 6th year in November, where one of our partners Genpharm will be sharing their expertise and experience from within the MENA region.

GENPHARM is a specialty pharmaceutical marketing company. It provides fast-track market access to innovative and specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. They focus on areas of unmet medical need, particularly in rare and genetic diseases with niche and orphan drugs.

If you would like to get an early preview and hear from the founders and employees about how they are contributing to the community and empowering the Rare Disease Community in the MENA region, then please watch their video here.

If you would like more information and to meet them personally then please join us to attend the World Orphan Drug Congress on November 11-13th in Geneva.

The Congress was one of the first events to bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers. It continues to be a key meeting for the sector in pushing forward with strategy, advocacy and partnering within the rare disease space.